Skip to main content
. Author manuscript; available in PMC: 2015 Mar 30.
Published in final edited form as: Eur Urol. 2011 May 25;60(5):964–971. doi: 10.1016/j.eururo.2011.05.032

Table 3. Summary statistics of surgical and pathologic parameters by presurgical therapy.

No. (%)

Characteristic All patients (n = 173) Immediate surgery (n = 103) Presurgical therapy (n = 70) p value
Pathologic tumor size, cm, median (range) 10 (1.7–27) 10 (2–27) 10 (1.7–24) 0.397

Duration of surgery, min, median (range) 185 (61–665) 182 (61–649) 196 (62–665) 0.638

EBL, ml, median (range) 600 (25–14 000) 600 (25–14 000) 700 (50–8900) 0.464

Pathologic T category: 0.674
 T1 and T2 27 (15.6) 15 (14.6) 12 (17.1)
 T3 and T4 146 (84.4) 88 (85.4) 58 (82.9)

Pathologic N category: 0.047
 Nx 55 (31.8) 40 (38.8) 15 (21.4)
 N0 61 (35.3) 34 (33) 27 (38.6)
 N1 and N2 57 (32.9) 29 (28.2) 28 (40)

LND: 0.020
 None 55 (31.8) 40 (38.8) 15 (21.4)
 Partial plus total 118 (68.2) 63 (61.2) 55 (78.6)

Matted nodes present 15 (12.7) 6 (9.5) 9 (16.4) 0.284

Presence of sarcomatoid features 29 (16.8) 14 (13.6) 15 (21.4) 0.214

Laparoscopic 31 (17.9) 15 (14.6) 16 (22.9) 0.225

PN 6 (3.5) 2 (1.9) 4 (5.7) 0.224

EBL = estimated blood loss; LND = lymph node dissection; PN = partial nephrectomy.